Induced Pluripotent Stem Cell (iPSC) Market 2024-2033 Trends, Opportunities, Size, Trends And Forecast

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $4.81 billion In 2028 At A CAGR Of 10.0% :

The induced pluripotent stem cell (ipsc) market size has grown rapidly in recent years. It will grow from $2.97 billion in 2023 to $3.29 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing healthcare expenditure, a rise in funding, rising awareness of stem cell products' medicinal potential, use of induced pluripotent stem cell (ipsc) based drug discovery, increasing demand for personalized medicine and cost-effective benefits of ipsc for drug discovery.

The induced pluripotent stem cell (ipsc) market size is expected to see rapid growth in the next few years. It will grow to $4.81 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to an increasing prevalence of chronic diseases, growth in genomic projects, development of ipsc-derived disease models, an increasing prevalence of genetic diseases, government initiatives and a rapid increase in technology. Major trends in the forecast period include development of pluripotent stem cells for parkinson's disease (pd), strategic collaborations and partnerships, development of induced pluripotent stem cell ipsc-derived nk cells, development of induced pluripotent stem cell (ipsc) for cell therapy, investment in regenerative medicine research and development, development of ipsc expansion medium, development of personalized ipsc and development of pluripotent stem cells for type i diabetes.

Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

Induced Pluripotent Stem Cell (iPSC) Market Major Segments
The induced pluripotent stem cell (ipsc) market covered in this report is segmented -
1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types
2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy
3) By End-User: Hospitals, Research Laboratories

Key Driver - Rising Chronic Disorders Prevalence Driving Growth In The Induced Pluripotent Stem Cell Market

An increase in the prevalence of chronic disorders is one of the major factors that is driving the growth of the induced pluripotent stem cell market. Chronic disorders such as heart disease, cancer, stroke, diabetes can be treated with Induced pluripotent stem cell. Induced Pluripotent stem cells are taken from any tissues from a child or an adult and are genetically modified to behave such as embryonic stem cells. According to the report published by Partnership to Fight Chronic Disorder (PFCD), it was found that out of 133 million Americans, 45% of the population had at least one chronic disorder. Moreover, it was estimated that 7 out of 10 deaths in the USA, which is approximately 1.7 million, are due to chronic disorders and these deaths can be controlled by induced pluripotent stem cell treatment. This rise in incidences of chronic diseases is driving the demand for induced pluripotent stem cell treatment market.

Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=2515&type=smp

Prominent Trend - Strategic Collaborations Drive Expansion In The Induced Pluripotent Stem Cell Market

Companies in the Induced Pluripotent stem cell market are looking for opportunities for strategic partnerships and collaborations that will help these companies to enter into new geographies and to expand product portfolios. For example, in January 2022, Bristol Myers Squibb and Century Therapeutics entered into a strategic collaboration to develop iPSC-derived allogenic cell therapies for the treatment of acute myeloid leukemia and multiple myeloma. Furthermore, in May 2022, Evotec and Sernova announced strategic partnership to develop iPSC-based beta cell replacement therapy for treatment for type 1 and type 2 diabetes.

Induced Pluripotent Stem Cell (iPSC) Market Players
Major companies operating in the induced pluripotent stem cell (ipsc) market report are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio, Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, Takaria Bio, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, MSD, Pfizer, Roche, Pharmasyntez, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, GlaxoSmithKline, Parexel, Bayer, Fate Therapeutics, Athersys, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, VistaGen Therapeutics, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Banco de Cordon del Peru, CryoHoldco, CellSave Arabia, Life Cell, AmiCare, Cells4life, ReeLabs, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the induced pluripotent stem cell (iPSC) market in 2023. Western Europe was the second largest region in the global induced pluripotent stem cell (iPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Induced Pluripotent Stem Cell (iPSC) Market Report Structure
3. Induced Pluripotent Stem Cell (iPSC) Market Trends And Strategies
4. Induced Pluripotent Stem Cell (iPSC) Market - Macro Economic Scenario
5. Induced Pluripotent Stem Cell (iPSC) Market Size And Growth
…..
27. Induced Pluripotent Stem Cell (iPSC) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.